HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,594 | -70.9% | 297,000 | -71.4% | 0.00% | – |
| Q2 2023 | $861,900 | -73.4% | 1,040,000 | -72.8% | 0.00% | – |
| Q1 2023 | $3,244,269 | -2.5% | 3,828,000 | +11.8% | 0.00% | – |
| Q4 2022 | $3,326,018 | +13.7% | 3,425,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,924,000 | -18.2% | 3,425,000 | -16.1% | 0.00% | – |
| Q2 2022 | $3,574,000 | -0.1% | 4,080,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,579,000 | – | 4,080,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 70,776,482 | $60,420,911 | 4.46% |
| Lombard Odier Asset Management (Europe) Ltd | 41,798,000 | $35,110,320 | 1.74% |
| CAMDEN ASSET MANAGEMENT L P /CA | 47,123,000 | $39,937,073 | 1.34% |
| Penn Mutual Asset Management | 1,555,000 | $1,318,197 | 1.25% |
| DAVIDSON KEMPNER PARTNERS | 66,537,000 | $56,390,573 | 1.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 66,537,000 | $56,390,573 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,443,000 | $8,011 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,934,000 | $7,582,430 | 0.58% |
| CSS LLC/IL | 8,000,000 | $6,788,288 | 0.45% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,262,534 | 0.40% |